CTLA4-Ig sustains osteogenic potential and inhibits osteoclastogenesis in Staphylococcus aureus osteomyelitis

Rongjie Lin1, Yiqing Huang1, Zhenbin Chen1

  • 1Department of Orthopedic Surgery, Fujian Medical University Union Hospital, Fuzhou, 350001, China.

Bone
|November 18, 2025
PubMed

Insights

Cytotoxic T-lymphocyte-associated protein 4 (CTLA4)-Ig shows promise for treating osteomyelitis (OM). It promotes bone regeneration and reduces bone destruction by modulating the immune microenvironment, offering a dual therapeutic approach.

Area of Science:

  • Immunology
  • Orthopedics
  • Regenerative Medicine

Background:

  • Osteomyelitis (OM) is a severe bone disease involving infection and inflammation.
  • Identifying key regulators for immune modulation and bone regeneration is crucial for OM treatment.

Purpose of the Study:

  • To investigate the role of CTLA4 in osteomyelitis.
  • To evaluate the therapeutic potential of CTLA4-Ig in promoting bone regeneration and inhibiting bone destruction in OM.

Main Methods:

  • Transcriptomic analysis of OM datasets (GSE18043, GSE30119).
  • Bioinformatic and immune infiltration analyses.
  • In vitro studies using MC3T3-E1 cells.
  • In vivo studies using a Staphylococcus aureus-induced rat OM model.

Main Results:

  • CTLA4 expression correlated with anti-inflammatory macrophage infiltration and Wnt/β-catenin pathway activation.
  • CTLA4-Ig promoted osteogenic differentiation and matrix mineralization in vitro.
  • CTLA4-Ig inhibited osteoclast formation and bone resorption in vitro.
  • CTLA4-Ig treatment in vivo enhanced osteoblast activity, reduced osteoclast presence, and improved bone structural integrity.
  • CTLA4-Ig modulated the inflammatory microenvironment, reducing pro-inflammatory cytokines and bacterial burden.

Conclusions:

  • CTLA4 is a key regulator in osteomyelitis, influencing immune modulation and osteogenic differentiation.
  • CTLA4-Ig demonstrates dual action, promoting bone regeneration while inhibiting bone destruction.
  • CTLA4-Ig represents a promising therapeutic strategy for osteomyelitis by modulating the inflammatory microenvironment and enhancing bone repair.

Related Concept Videos

Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
3.8K
Hormones and Bone Tissue01:17

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
3.6K
Bone Cells and Tissue01:30

Bone Cells and Tissue

Bones contain a relatively small number of cells entrenched in a matrix of organic and inorganic components. Although bone cells compose only a small amount of the bone volume, they are crucial to its function. Four types of cells are found within the bone tissue— osteoblasts, osteocytes, osteogenic cells, and osteoclasts.
Osteoblasts and Osteocytes
The osteoblast is the bone cell responsible for forming new bone tissue. It is found in the growing portions of bone, including the...
7.9K